Regulation

FATE Therapeutics Inc Form 144 Filed on 20 May 2023

Published on 5/20/2026

#FATE#SEC#Form144
FATE Therapeutics Inc Form 144 Filed on 20 May 2023

AI Summary

Summarized by AI from the source below

On 20 May 2023, FATE Therapeutics Inc (FATE) filed Form 144 with the SEC. This form is utilized for the sale of restricted and control securities, indicating potential stock sales by insiders or affiliates. The filing is part of regular regulatory requirements, ensuring transparency in equity transactions. Monitoring these filings can provide insight into shareholder sentiment and potential market movements.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Passenger Removed from Flight at PDX After TSA Finds Marijuana
Regulation

Passenger Removed from Flight at PDX After TSA Finds Marijuana

Jul 4

Trump Pardons 11 Individuals for Violating Clean Air Act
Regulation

Trump Pardons 11 Individuals for Violating Clean Air Act

Jul 4

New Jersey Deli Fraud Sentencing Recommendations: $100M Case Insights
Regulation

New Jersey Deli Fraud Sentencing Recommendations: $100M Case Insights

Jul 3

Kismet Kebabs Fined Β£500K for Fraud Involving Lamb Kebabs
Regulation

Kismet Kebabs Fined Β£500K for Fraud Involving Lamb Kebabs

Jul 3